<DOC>
	<DOCNO>NCT01281657</DOCNO>
	<brief_summary>The purpose observational study collect long-term data safety effectiveness fingolimod , particularly include clinical disease patient outcome related parameter relapse disability , patient participate prior trial within fingolimod clinical development program . Furthermore , study explores incidence select safety relate outcomes fingolimod treatment follow-up visit within context routine medical practice .</brief_summary>
	<brief_title>Long Term Study Fingolimod MS Patients From FTY Clinical Program</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Patients prescribe fingolimod part routine medical care Patients participate prior fingolimod clinical trial Restrictions regard use fingolimod pregnant nursing accordance local prescribe label Any patient prematurely discontinue previous fingolimod trial Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Fingolimod</keyword>
	<keyword>FTY720</keyword>
	<keyword>Relapsing form multiple sclerosis</keyword>
	<keyword>Multiple sclerosis</keyword>
	<keyword>MS</keyword>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
</DOC>